Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|36|5|294-307

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.36, Iss.5, 2015-07, pp. : 294-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet function is better preserved by aprotinin than tranexamic acid in patients undergoing cardiac surgery

By  

Inpharma, Vol. 1, Iss. 1652, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Clopidogrel Activities in Patients with Renal Function Impairment

By deray G.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 319-328

Adis International

Access to resources Recommend Favorite

Antiretroviral Therapy: Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment

By McCabe Sarah M.   Qing   Slish Judianne C.   Catanzaro Linda M.   Sheth Neha   DiCenzo Robert   Morse Gene D.  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 153-172

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of Gepirone in Subjects with Normal Renal Function and in Patients with Chronic Renal Dysfunction

By Dogterom P.  

Clinical Drug Investigation, Vol. 22, Iss. 8, 2002-08 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

High renal impairment rate with zoledronic acid in cancer patients

By  

Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite